Monday, 2 July 2018

Global SPECT Radiopharmaceuticals Market Professional Survey Report 2018

This report studies the global SPECT Radiopharmaceuticals market status and forecast, categorizes the global SPECT Radiopharmaceuticals market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

The global SPECT Radiopharmaceuticals market is valued at xx million US$ in 2017 and is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx.x % between 2018 and 2025.

The major manufacturers covered in this report
  • Cardinal Health Inc. (U.S.)
  • Mallinckrodt plc (Ireland)
  • GE Healthcare (U.K.)
  • Lantheus Medical Imaging, Inc. (U.S.)
  • Bayer Healthcare (Germany)
  • Bracco Imaging S.p.A (Italy)
  • Eczacibasi-Monrol Nuclear Products (Turkey)
  • Nordion, Inc. (Canada)
  • Advanced Accelerator Applications S.A. (France)
  • IBA Molecular Imaging (Belgium)
Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
  • North America
  • Europe
  • China
  • Japan
  • India
  • Southeast Asia
  • Other regions (Central & South America, Middle East & Africa)
The regional scope of the study is as follows:
  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Singapore
  • Rest of Asia-Pacific
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Central & South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Saudi Arabia
  • Turkey
  • Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Tc-99
  • Tl-201
  • Ga-67
  • I-123
  • Others
By Application, the market can be split into
  • Diagnostics
  • Therapeutics
The study objectives of this report are:
  • To analyze and study the global SPECT Radiopharmaceuticals capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
  • Focuses on the key SPECT Radiopharmaceuticals manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of SPECT Radiopharmaceuticals are as follows:
  • History Year: 2013-2017
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
  • SPECT Radiopharmaceuticals Manufacturers
  • SPECT Radiopharmaceuticals Distributors/Traders/Wholesalers
  • SPECT Radiopharmaceuticals Subcomponent Manufacturers
  • Industry Association
  • Downstream Vendors
Available Customizations
With the given market data, we offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the SPECT Radiopharmaceuticals market, by end-use.
Detailed analysis and profiles of additional market players.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)